Bone metabolism effects of medical therapy in advanced renal cell carcinoma

RM Paragliola, F Torino, A Barnabei, GM Iannantuono… - Cancers, 2023 - mdpi.com
Simple Summary Tyrosine kinase inhibitors and immune checkpoint inhibitors have
substantially prolonged survival in patients affected by advanced renal cell carcinoma …

Exploring the impact of novel anti-cancer therapies on jaw osteonecrosis and other bones: A comprehensive review

W Konarski, T Poboży, K Konarska… - Journal of Clinical …, 2024 - mdpi.com
Osteonecrosis is a debilitating condition characterized by the loss of blood supply to the
bones, leading to bone death. This condition can impact various bones, including the jaw …

[HTML][HTML] Medication-Related Osteonecrosis of the Jaw: A Systematic Review of Case Reports and Case Series

F Frutuoso, F Freitas, M Vilares, H Francisco… - Diseases, 2024 - mdpi.com
Medication-related osteonecrosis of the jaw (MRONJ) is a rare condition, typically seen in
patients receiving antiresorptive or antiangiogenic drugs. This study aims to synthesize …

Medication-related osteonecrosis of the jaw: evolving research for multimodality medical management

A Abdolrahmani, JB Epstein, F Samim - Supportive Care in Cancer, 2024 - Springer
Purpose Medication-related osteonecrosis of the jaw (MRONJ) is a debilitating side effect of
antiresorptive and antiangiogenic agents that can lead to progressive bone destruction in …

[HTML][HTML] Medication-related osteonecrosis of the jaw: successful medical management of complex maxillary alveolus with sinus involvement

JB Epstein, PR Arany, SE Yost, Y Yuan - Case Reports in Oncology, 2023 - karger.com
Medication-related osteonecrosis of the jaw (MRONJ) in cancer patients presents a
considerable challenge in management. Current management is primarily based on …

Analysis of the Degree of Information of Dental Surgeons about Antiresorptive Drugs According to the Time Since Graduation in Dentistry

FGCW Rocha, RPC Araújo - Pesquisa Brasileira em Odontopediatria …, 2023 - SciELO Brasil
Objective: To determine the level of scientific information of dental surgeons who carry out
their professional activities in Brazil about antiresorptive drugs and indicated …

Correlated Multimodal Imaging in Bone of Regeneration-A Showcase of Bisphosphonate-Treated Murine Jawbones

P Bhattacharjee, A Szabo, P Dungel, C Streli… - Bioimaging in Tissue …, 2024 - Springer
The bone is a tissue that is capable of repair and regeneration in response to traumatic
injuries. However, bone diseases have become a serious health issue worldwide caused by …

Osteonecrosis of the Jaw in Patients with Clear Cell Renal Cell Carcinoma Treated with Targeted Agents: A Case Series and Large-Scale Pharmacovigilance …

S Wang, Y Song, D Yin, F Xiao, L Xue, X Wang - 2024 - researchsquare.com
Objective: We use the public database to describe and evaluate ONJ related to various
tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) treated for renal cell …

Medicamentos antirreabsortivos: perfil técnico-científico dos cirurgiões-dentistas

FGCW Rocha - 2023 - repositorio.ufba.br
Introduction-Antiresorptive drugs are medications frequently used in the treatment of bone
disorders and metastatic malignancies. However, chronic use of these medications can …

Low-level laser therapy protocols for dentistry: an integrative review: Protocolos de laserterapia de baixa potência para odontologia: uma revisão integrativa

DRS Santos, SCB Diniz, AF de Castro, MB Pains - Concilium, 2024 - clium.org
The interest in the uses and effects of low-level laser therapy has significantly increased in
dentistry. This study aimed to indicate the ways of use, dosimetric parameters, and modes of …